XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.22.2.2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details) | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Sep. 30, 2022 USD ($) | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) item | Sep. 30, 2021 USD ($) | Dec. 31, 2021 USD ($)
Revenue recognition |  |  |  |  |
Estimated contractual allowance | $ 2,700,000 |  | $ 2,700,000 |  | $ 6,200,000
Period for return of incorrect domestic shipments |  |  | 10 days |  |
Number of times overstocking returns are limited | item |  |  | 2 |  |
Period for return of product due to overstock |  |  | 12 months |  |
Maximum percentage of distributor's total purchase for the prior 12-month period |  |  | 1.00% |  |
License revenue payable to patent owner, as a percent |  |  | 50.00% |  |
Revenue recognized from contracts with customers and licensing fees recognized | 23,061,285 | $ 36,356,047 | $ 82,140,204 | $ 128,926,716 |
U.S. | U.S. sales (excluding U.S. government) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 9,197,133 | 15,653,047 | 28,971,783 | 39,336,134 |
U.S. | Sales to U.S. government |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized |  | 18,420,480 | 15,731,136 | 83,560,680 |
North and South America (excluding U.S.) | North and South America sales (excluding U.S.) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 9,841,536 | 701,802 | 24,657,232 | 3,161,418 |
Other international | Other international sales |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 4,022,616 | 1,580,718 | 12,780,053 | 2,868,484 |
Syringes |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 20,688,078 | 31,513,599 | 74,791,929 | 119,371,010 |
Syringes | U.S. | U.S. sales (excluding U.S. government) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 6,947,856 | 11,033,291 | 22,220,324 | 30,685,338 |
Syringes | U.S. | Sales to U.S. government |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized |  | 18,420,480 | 15,731,136 | 83,560,680 |
Syringes | North and South America (excluding U.S.) | North and South America sales (excluding U.S.) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 9,825,120 | 670,602 | 24,421,790 | 2,963,930 |
Syringes | Other international | Other international sales |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 3,915,102 | 1,389,226 | 12,418,679 | 2,161,062 |
Blood Collection Products |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 824,554 | 565,765 | 2,675,119 | 1,659,231 |
Blood Collection Products | U.S. | U.S. sales (excluding U.S. government) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 815,964 | 560,065 | 2,419,915 | 1,590,891 |
Blood Collection Products | North and South America (excluding U.S.) | North and South America sales (excluding U.S.) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized |  | 4,800 |  | 4,800 |
Blood Collection Products | Other international | Other international sales |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 8,590 | 900 | 255,204 | 63,540 |
EasyPoint Needles |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 1,523,784 | 4,264,684 | 4,400,631 | 7,743,240 |
EasyPoint Needles | U.S. | U.S. sales (excluding U.S. government) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 1,426,060 | 4,048,292 | 4,294,603 | 7,019,560 |
EasyPoint Needles | North and South America (excluding U.S.) | North and South America sales (excluding U.S.) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized |  | 26,400 | 2,608 | 83,248 |
EasyPoint Needles | Other international | Other international sales |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 97,724 | 189,992 | 103,420 | 640,432 |
Other Products |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 24,869 | 11,999 | 272,525 | 153,235 |
Other Products | U.S. | U.S. sales (excluding U.S. government) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 7,253 | 11,399 | 36,941 | 40,345 |
Other Products | North and South America (excluding U.S.) | North and South America sales (excluding U.S.) |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | 16,416 |  | 232,834 | 109,440 |
Other Products | Other international | Other international sales |  |  |  |  |
Revenue recognition |  |  |  |  |
Revenue recognized from contracts with customers and licensing fees recognized | $ 1,200 | $ 600 | $ 2,750 | $ 3,450 |

X
- Definition The percentage of revenue from licensing agreements that is payable to the owner of certain patented technology under certain conditions. + References No definition available. + Details
Name: | rvp_LicenseRevenuePercentagePayableToPatentOwner
Namespace Prefix: | rvp_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the maximum percentage of distributor's total purchase in prior 12-month period for overstock return. + References No definition available. + Details
Name: | rvp_RevenueRecognitionMaximumPercentageOfDistributorsTotalPurchaseInPriorTwelveMonthPeriodForOverstockReturn
Namespace Prefix: | rvp_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of overstock returns available to a customer within a specified period of time. + References No definition available. + Details
Name: | rvp_RevenueRecognitionOverstockReturnLimitNumber
Namespace Prefix: | rvp_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The period of time specified for overstock returns. + References No definition available. + Details
Name: | rvp_RevenueRecognitionOverstockReturnPeriod
Namespace Prefix: | rvp_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the period for return of incorrect shipments, following arrival at the distributor's facility. + References No definition available. + Details
Name: | rvp_RevenueRecognitionPeriodForReturnOfIncorrectShipments
Namespace Prefix: | rvp_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 55 -Paragraph 27 -URI https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046 + Details
Name: | us-gaap_ContractWithCustomerRefundLiabilityCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=rvp_UnitedStatesCustomersExcludingUnitedStatesGovernmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=rvp_U.s.GovernmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=rvp_NorthAndSouthAmericaExcludingUnitedStatesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=rvp_CustomersInNorthAndSouthAmericaExcludingUnitedStatesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=rvp_InternationalExcludingNorthAndSouthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=rvp_InternationalCustomersExcludingNorthAndSouthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rvp_SyringesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rvp_BloodCollectionProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rvp_EasyPointNeedlesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=rvp_OtherProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |